Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0144162001
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02496933 | AMGEN CANADA INC | AVSOLA | Human | Yes | Prescription | 1 | INFLIXIMAB | 100 MG / VIAL |
Marketed | 02496933 | AMGEN CANADA INC | AVSOLA | Human | Yes | Schedule D | 1 | INFLIXIMAB | 100 MG / VIAL |
Marketed | 02419475 | CELLTRION INC. | INFLECTRA | Human | Yes | Prescription | 1 | INFLIXIMAB | 100 MG / VIAL |
Marketed | 02419475 | CELLTRION INC. | INFLECTRA | Human | Yes | Schedule D | 1 | INFLIXIMAB | 100 MG / VIAL |
Approved | 02523191 | PFIZER CANADA ULC | IXIFI | Human | Yes | Prescription | 1 | INFLIXIMAB | 100 MG / VIAL |
Approved | 02523191 | PFIZER CANADA ULC | IXIFI | Human | Yes | Schedule D | 1 | INFLIXIMAB | 100 MG / VIAL |
Approved | 02510308 | JANSSEN INC | OMVYENCE | Human | Yes | Prescription | 1 | INFLIXIMAB | 100 MG / VIAL |
Approved | 02510308 | JANSSEN INC | OMVYENCE | Human | Yes | Schedule D | 1 | INFLIXIMAB | 100 MG / VIAL |
Marketed | 02244016 | JANSSEN INC | REMICADE | Human | Yes | Schedule D | 1 | INFLIXIMAB | 100 MG / VIAL |
Marketed | 02244016 | JANSSEN INC | REMICADE | Human | Yes | Prescription | 1 | INFLIXIMAB | 100 MG / VIAL |
Dormant | 02419483 | CELLTRION INC. | REMSIMA | Human | Yes | Prescription | 1 | INFLIXIMAB | 100 MG / VIAL |
Dormant | 02419483 | CELLTRION INC. | REMSIMA | Human | Yes | Schedule D | 1 | INFLIXIMAB | 100 MG / VIAL |
Marketed | 02470373 | SAMSUNG BIOEPIS CO., LTD | RENFLEXIS | Human | Yes | Schedule D | 1 | INFLIXIMAB | 100 MG / VIAL |
Marketed | 02470373 | SAMSUNG BIOEPIS CO., LTD | RENFLEXIS | Human | Yes | Prescription | 1 | INFLIXIMAB | 100 MG / VIAL |
Application information
Related information
Contact us
Version 4.0.3